Racial Disparities in the Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis as Urate-Lowering Drug Adverse Events in the United States

Seminars in Arthritis and Rheumatism - United Kingdom
doi 10.1016/j.semarthrit.2016.03.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the United States

Journal of the American Academy of Dermatology
Dermatology
2017English

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

JAMA Dermatology
DermatologyMedicine
2015English

Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

New Insights in Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis Syndrome

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Oncologic Considerations

Clinical Journal of Oncology Nursing
Oncology
2004English

The Current Understanding of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Expert Review of Clinical Immunology
AllergyImmunology
2011English

Readmission Risk Factors and Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Cureus
2020English

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Zonisamide

Clinical Case Reports
Medicine
2017English

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients From the United States

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy